Martin Roper
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
Highest-materiality recent filing
MGP shareholders elect directors, ratify KPMG, approve say-on-pay and 2024 equity plan
All four Group A director nominees elected: Julie M. Francis (~17.8M for), Thomas A. Gerke (~15.4M for), Donn Lux (~16.9M for), Todd B. Siwak (~14.7M for).
MGP Ingredients Q1 net loss $134.8M on $179.5M non-cash impairments; adj. EPS $0.15
Revenue fell 13% to $106.4M; net loss of $134.8M ($6.30 basic loss) vs year-ago loss of $3.0M.
Temporary idling of Limestone Branch (Lebanon, KY) and Lux Row (Bardstown, KY) effective May 1, 2026.
MGP Ingredients Q4 net loss $134.6M includes $152.6M impairment; FY sales -24%
Q4 net loss of $134.6M, includes $152.6M non-cash goodwill/intangibles impairment (Branded Spirits).
MGP Ingredients terminates CHRO and CCO as part of leadership reorganization
Board approved reorganization; CHRO Erika Lapish and CCO Amel Pasagic depart effective Feb 20, 2026.
Karen Seaberg retired from MGP Board effective December 14, 2025 after over 15 years of service, including as Chairman from 2014 to 2024.
MGP Ingredients Q3 sales -19% to $130.9M, net income -35%; raises FY adjusted EBITDA, EPS outlook
Q3 consolidated sales $130.9M (-19% YoY); gross profit $49.4M (-25%); net income $15.4M (-35%).
MGP Ingredients Q2 sales -24% to $145.5M, net income -55%; new CEO Julie Francis appointed
Sales down 24% to $145.5M; gross profit -30% to $58.4M; margin 40.1% (-350bps).
MGP Ingredients appoints Julie Francis as CEO; reaffirms FY2025 guidance
Julie Francis named President and CEO effective July 21, 2025; previously COO at Schwan's Company.
MGP Ingredients elects Martin Roper as Chairman; appoints new committee chairs
Martin Roper elected Chairman of the Board effective May 22, 2025; has 25+ years beverage industry experience including CEO of Boston Beer and Vita Coco.
MGP Ingredients Q1 net loss $3.1M; sales down 29%, reaffirms 2025 outlook
Net loss of $3.1M vs $19.9M income in Q1 2024; basic EPS loss $0.14.
MGP Ingredients upsizes revolver to $500M, extends maturity to 2030
Revolving credit facility increased from $400M to $500M.
MGP Ingredients elects Gerardo Lopez and Martin Roper to board; Preet Michelson resigns
Gerardo I. Lopez (former CEO of AMC Entertainment) and Martin Roper (CEO of Vita Coco, former CEO of Boston Beer) elected as Group B directors effective April 14, 2025.
MGP Ingredients adopts new LTI program with PSUs and updated RSU awards
Committee approved new LTI design: annual grants of PSUs with forward-looking performance goals and time-vested RSUs, effective 2025.
Three MGP Ingredients directors plan to sell shares under 10b5-1 plans
Donn Lux, Karen Seaberg, and Lori Mingus expected to sell MGPI common stock.
MGP Ingredients Q4 net loss $42M on goodwill impairment; 2025 guidance well below 2024
Q4 net loss $42M ($1.91 basic EPS loss) includes $73.8M non-cash goodwill impairment; adjusted EPS $1.57.
MGP Ingredients approves amended Short Term Incentive Plan effective Jan 1, 2025
Amended STIP effective Jan 1, 2025; cash bonus pool set at at least 80% of collective target bonuses.
MGP Ingredients names CFO Brandon Gall interim CEO; Donn Lux becomes chairman
David Bratcher steps down as CEO and resigns from board effective Dec 31, 2024; gets transition and severance benefits.
Consolidated sales $161.5M, down 24% YoY; excluding Atchison distillery, down 14%.
MGP Ingredients preliminary Q3 sales down 24%, cuts full-year guidance significantly
Preliminary Q3 sales $161.5M, -24% YoY; net income $23.9M (+82%) but adjusted EPS down 5% to $1.29.
Requires stockholders using Universal Proxy Rules to provide evidence of Rule 14a-19 compliance.
MGP Ingredients amends bylaws to address Universal Proxy Rules and update governance provisions
Board approved amended bylaws effective September 26, 2024.
MGP Ingredients Q2 2024: adjusted EPS up 15% to $1.71; reaffirms FY guidance
Sales fell 9% to $190.8M due to Atchison closure; ex-distillery, sales up 7%.
MGP Ingredients shareholders elect nine directors, approve new equity plan at 2024 annual meeting
All four common-stock director nominees elected with >18.2M votes each; broker non-votes of 1.29M.
MGP Ingredients Q1 net income down 34% to $20.6M; reaffirms FY2024 guidance
Sales decreased 15% to $170.6M; gross profit down 10% to $62.8M.
MGP Ingredients Chief Legal Officer Curtis Landherr resigns; transition period through May 31, 2024
Curtis Landherr, Chief Legal Officer, VP, and Corporate Secretary, resigns effective May 31, 2024; officer roles end April 30.
MGP Ingredients Q4 2023 sales up 13%; adj. diluted EPS $1.64 vs $1.01; FY2024 guide
Q4 sales $214.9M (+13%), gross profit $85.1M (+35%), adjusted diluted EPS $1.64 vs $1.01 YoY.
MGP Ingredients VP of Production & Engineering to retire July 31, 2024
Stephen J. Glaser, Vice President of Production and Engineering, notified his retirement effective July 31, 2024.
David Bratcher elected to MGP Ingredients Board, effective Jan 1, 2024
Bratcher elected as Group B director by preferred stockholders at special meeting.
MGP Ingredients Q3 sales up 5% to $211.6M; CEO Colo to retire, Bratcher named successor
Q3 sales $211.6M (+5% YoY); gross profit $73.4M (+24%); adjusted diluted EPS $1.34 vs $1.06 YoY.
MGP Ingredients increases shelf facility to $250M, extends through Aug 2026
Maximum principal under shelf facility increased from $140M to $250M, subject to conditions and purchaser discretion.
MGP Ingredients reports record Q2 sales $209M, net income up 26%; raises FY2023 guidance
Q2 sales $209.0M (+7% YoY); net income $32.0M (+26%); diluted EPS $1.44 vs $1.15.
MGP Ingredients to close Atchison distillery; FY2023 charges $23-31M
Closure of grain neutral spirits and industrial alcohol distillery expected by January 2024.
MGP Ingredients reports annual meeting results; all director nominees elected
Nine directors elected to two classes: four Group A (Common Stock) and five Group B (Preferred Stock).
MGP Ingredients Q1 sales up 3% to $201M; net income down 17% to $31M; reaffirms FY guidance
Diluted EPS fell to $1.39 from $1.69 YoY; adjusted EBITDA down 15% to $47.1M.
MGP Ingredients reports record FY2022 sales up 25% to $782.4M; net income up 20%
Q4 sales $191.0M (+15% YoY); adjusted diluted EPS $1.01 vs $0.88.
MGP Ingredients modifies RSU agreements: lowers retirement age to 60, adds dual-trigger CIC vesting
Retirement redefined as age 60 with 5 years of service (previously age 65, no service requirement).
MGP Ingredients Q3 sales up 14% to $201.2M; raises FY2022 guidance
Q3 sales $201.2M (+14% YoY); net income $23.6M vs $23.7M; diluted EPS $1.06 vs $1.08.
MGP Ingredients VP of Alcohol Sales David Dykstra to retire Dec 31, 2022
David Dykstra, VP of Alcohol Sales, plans retirement effective December 31, 2022.
MGP Ingredients Q2 2022 sales up 11% to $195M; net income up 26%; raises FY guidance
Sales $195.0M (+11% YoY); operating income $35.3M (+28%); net income $25.4M (+26%).
MGP grants COO Bratcher enhanced severance with RSU acceleration upon qualifying termination
Bratcher receives full vesting of outstanding unvested RSUs upon termination without cause or for good reason.
MGP Ingredients removes two VPs from Section 16 officer list after leadership realignment
David Dykstra (VP Alcohol Sales) and Stephen Glaser (VP Production & Engineering) cease being Section 16 reporting officers.
MGP Ingredients stockholders elect nine directors, ratify KPMG, approve say-on-pay
Group A directors elected by common stock: Gerke, Lux, Rauckman, Siwak with >18.6M for each.
Q1 sales up 80.2% to $195.2M; EPS $1.69 vs $0.90
Sales $195.2M (+80.2% YoY); operating income $50.1M (+144.3%).
MGP Ingredients reports record FY2021 sales of $626.7M (+58.5%), raises 2022 guidance
Full-year diluted EPS rose to $4.34 from $2.37; adjusted EPS $4.24 vs $2.51.
MGP Ingredients closes $201.2M 1.875% convertible note offering due 2041
$201.2M notes (incl. full $26.25M greenshoe) with 1.875% coupon, due Nov 2041, sold in 144A placement.
MGP Ingredients prices $175M convertible notes offering to reduce revolving credit facility debt
Priced $175 million aggregate principal amount of 1.875% convertible senior notes due 2041 in a private offering.
Pro forma combined sales $503.7M, net income $55.6M, diluted EPS $2.53 for YTD Sept 30, 2021.
MGP Ingredients Q3 sales up 71.5% to $176.6M, EPS $1.08, raises full-year guidance
Consolidated sales $176.6M (+71.5%), gross profit $57.1M (+146.5%), operating income $32.9M (+140.9%).
MGP files Luxco Q1 2021 financials: net loss of $2.6M on $9M merger costs
Luxco net loss of $2.617M for Q1 2021 vs net income of $5.634M in Q1 2020.
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
In addition, Preet H. Michelson resigned as a Group B member of the Board, effective April 14, 2025.
On April 22, 2024, Curtis C. Landherr, the Chief Legal Officer, Vice President, and Corporate Secretary and a named executive officer of MGP Ingredients, Inc. (the “Company”) notified the Company that he is resigning from the Company, effective May 31, 2024.
On January 12, 2024, Stephen J. Glaser, Vice President of Production and Engineering and a named executive officer of MGP Ingredients, Inc. (the “Company”), notified the Company that he will be retiring from his position effective July 31, 2024.
David S. Bratcher was elected as a Group B member of the Board of Directors (the “Board”) of MGP Ingredients, Inc. (the “Company”), effective January 1, 2024
Mr. Bratcher was also appointed to serve as the Company’s Chief Executive Officer and President, effective January 1, 2024
The Company will seek to have Mr. Bratcher elected as a Class B director of the Company effective January 1, 2024.
On August 5, 2022, MGP Ingredients, Inc. (the “Company”) entered into a letter agreement with David Dykstra, the Company’s Vice President of Alcohol Sales, in connection with his planned retirement from the Company on December 31, 2022.
As a result, David Dykstra, Vice President of Alcohol Sales, and Stephen Glaser, Vice President of Production and Engineering, two of the named executive officers listed in last year’s proxy statement have ceased to be Section 16 reporting officers.
As a result, David Dykstra, Vice President of Alcohol Sales, and Stephen Glaser, Vice President of Production and Engineering, two of the named executive officers listed in last year’s proxy statement have ceased to be Section 16 reporting officers.
On July 13, 2021, MGP Ingredients, Inc. (the “Company”) announced the appointment of David S. Bratcher as Chief Operating Officer, effective July 6, 2021.
Max materiality 0.90 · Median 0.60 · Most common event earnings